ESC 365 - Inflammation in atherosclerosis: translating science into practicable solutions.

EAPC Premium Access

Inflammation in atherosclerosis: translating science into practicable solutions.

Event: EuroPrevent 2018

Topic: Secondary Prevention

Session type: Satellite Symposium

Sponsored by Novartis Pharma AG

Date: 20 April 2018

Time: 12:45 - 13:45

Session

5 presentations in this session

Welcome and introduction - Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor U. Landmesser (Berlin, DE)

Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor P. Libby (Boston, US)

Clinical residual cardiovascular risk: what are the markers?

Speaker: Professor W. Koenig (Munich, DE)

Advancing standard of care in post-myocardial infarction (MI) patients with elevated high sensitivity C-reactive protein (hsCRP).

Speaker: Professor U. Landmesser (Berlin, DE)

Speaker: Professor P. Libby (Boston, US)

Speaker: Professor W. Koenig (Munich, DE)

Summary and closure - Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor U. Landmesser (Berlin, DE)

7 speakers from this session

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

34 presentations

1 follower

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)

28 presentations

2 followers

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)

20 presentations

0 follower

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

34 presentations

1 follower

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)

28 presentations

2 followers

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)

20 presentations

0 follower

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

34 presentations

1 follower

This platform is supported by